We are de-risking biomedical innovation, turning biomedical knowledge into social and economic value.
More than three decades later, we remain committed in pursuit of pharmaceutical innovation, providing high quality products and striving to deliver superior business results.
The patient is at the heart of what we do, making decisions regarding biometric innovation is usually a complicated and chaotic procedure as it consists of various product options, various facets to ascertain these on, and multiple evaluations at all levels.
Discover our therapeutic areas, where we continuously invest to innovate and deliver therapeutic solutions for patient’s benefit.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
18
Aug 2026
Workers who juggle volatile work hours that change from week to week may experience adverse health effects that impact their ability to work, although the limitations vary by gender, say researchers at the University of Illinois Urbana-Champaign who conducted a recent study.
18
Aug 2026
Childhood epilepsy is linked to significantly poorer exam grades and long term educational attainment, with the lowest levels of academic prowess among those whose neurological disorder started when they were very young, finds a large, long term Danish study, published online in the Journal of Neurology Neurosurgery & Psychiatry.
18
Aug 2026
Healthy sleep patterns in mid life are linked to longer working life expectancy, suggest the findings of a large study of working age men and women, published online in Occupational & Environmental Medicine.
18
Aug 2026
A landmark study of more than 3,400 children, led by Queen Mary University of London, has found that air quality improvements following the introduction of London's Ultra Low Emission Zone (ULEZ) are strongly associated with accelerated lung growth in children.